Impact of anxiety and depression on quality of life in gastric cancer patients receiving SOX neoadjuvant chemotherapy

doi:10.4251/wjgo.119170

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 7

This Article

(23)

(17)

(0)

(332)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Jul 15, 2026; 18(7): 119170
Published online Jul 15, 2026. doi: 10.4251/wjgo.119170

Table 5 Multi-dimensional correlation between anxiety, depression and quality of life

	Emotional	Cognitive	Social	Physical	Role	Global QoL
Anxiety (SAS)	-0.552^a	-0.051	-0.403^a	-0.369^a	-0.158	-0.539^a
Depression (SDS)	-0.599^a	-0.001	-0.471^a	-0.404^a	-0.148	-0.574^a

^aP < 0.001.

QoL: Quality of life; SDS: Self-Rating Depression; SAS: Self-Rating Anxiety.

Full Size Table

Citation: Cui BY, Zhang Z. Impact of anxiety and depression on quality of life in gastric cancer patients receiving SOX neoadjuvant chemotherapy. World J Gastrointest Oncol 2026; 18(7): 119170
URL: https://www.wjgnet.com/1948-5204/full/v18/i7/119170.htm
DOI: https://dx.doi.org/10.4251/wjgo.119170

Cui BY, Zhang Z. Impact of anxiety and depression on quality of life in gastric cancer patients receiving SOX neoadjuvant chemotherapy. World J Gastrointest Oncol 2026; 18(7): 119170 [DOI: 10.4251/wjgo.119170]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.